Literature DB >> 17581370

Returning to the pre-antibiotic era in the critically ill: the XDR problem.

David L Paterson, Jeffrey Lipman.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17581370     DOI： 10.1097/01.CCM.0000269352.39174.A4

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  13 in total

Review 1.  Structure--activity relationships of polymyxin antibiotics.

Authors:  Tony Velkov; Philip E Thompson; Roger L Nation; Jian Li
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

Review 2.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

Review 3.  Antimicrobial resistance in nephrology.

Authors:  Tina Z Wang; Rosy Priya L Kodiyanplakkal; David P Calfee
Journal:  Nat Rev Nephrol       Date:  2019-08       Impact factor: 28.314

4.  Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.

Authors:  Rachel L Soon; Roger L Nation; Stewart Cockram; Jennifer H Moffatt; Marina Harper; Ben Adler; John D Boyce; Ian Larson; Jian Li
Journal:  J Antimicrob Chemother       Date:  2010-11-16       Impact factor: 5.790

5.  Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species.

Authors:  Cheryl-lynn Y Ong; Scott A Beatson; Makrina Totsika; Christiane Forestier; Alastair G McEwan; Mark A Schembri
Journal:  BMC Microbiol       Date:  2010-06-24       Impact factor: 3.605

Review 6.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease.

Authors:  Gauri G Rao; Neang S Ly; Curtis E Haas; Samira Garonzik; Alan Forrest; Jurgen B Bulitta; Pamela A Kelchlin; Patricia N Holden; Roger L Nation; Jian Li; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

8.  Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation.

Authors:  Cheryl-Lynn Y Ong; Glen C Ulett; Amanda N Mabbett; Scott A Beatson; Richard I Webb; Wayne Monaghan; Graeme R Nimmo; David F Looke; Alastair G McEwan; Mark A Schembri
Journal:  J Bacteriol       Date:  2007-11-30       Impact factor: 3.490

9.  Nanoscale analysis of the effects of antibiotics and CX1 on a Pseudomonas aeruginosa multidrug-resistant strain.

Authors:  C Formosa; M Grare; E Jauvert; A Coutable; J B Regnouf-de-Vains; M Mourer; R E Duval; E Dague
Journal:  Sci Rep       Date:  2012-08-14       Impact factor: 4.379

10.  The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.

Authors:  Lisa C Crossman; Virginia C Gould; J Maxwell Dow; Georgios S Vernikos; Aki Okazaki; Mohammed Sebaihia; David Saunders; Claire Arrowsmith; Tim Carver; Nicholas Peters; Ellen Adlem; Arnaud Kerhornou; Angela Lord; Lee Murphy; Katharine Seeger; Robert Squares; Simon Rutter; Michael A Quail; Mari-Adele Rajandream; David Harris; Carol Churcher; Stephen D Bentley; Julian Parkhill; Nicholas R Thomson; Matthew B Avison
Journal:  Genome Biol       Date:  2008-04-17       Impact factor: 13.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.